{"name":"Clavis Pharma","slug":"clavis-pharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxQWDZZSmp5blUxZ0QwUUtCaEZVem1TWWpXQ01oOVRNMFN1QUI4VkF1a3dST3lweEJidVRoZDJZZW5sSUFwVFhLM1Vka053M3dsUmhtdDFSOXBxZlc2eU1UT1RhN1NDZGMtQnhObFF0LVBsR185VUZLQzAxZ2NTeFdXQWdnLXlHMkd6Q0VwQ2t0MWNnZFRVMzVhNTJjaGRKNUtoM00xVWpwem1mR04wOUZkLWdGdkdnbzRTcldNSUtCR3RGTkY2R2VLbWxicFdpUQ?oc=5","date":"2026-03-31","type":"pipeline","source":"AD HOC NEWS","summary":"HONG KONG, Mar 31, 2026 - (ACN Newswire) - On the evening of 30 March, Fosun International announced - AD HOC NEWS","headline":"HONG KONG, Mar 31, 2026 - (ACN Newswire) - On the evening of 30 March, Fosun International announced","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOUFVyNExkbkxPYy1Qd1otUHdNWmNGcVRDaFdLS1pteHZzYjBlRlMzYVpGV0FyX3NhOEN4S1A5WEVwQUZjcHNKTURYZjVSSkh3Z19ITXZ1SGtyVU9ORGllMGNnNjRjUzdNTEZmVlNRT0ZBanlxd2ZTUVFHbFluOU03ZGZWcWV5akducE84aEVzM0FOME5HekE?oc=5","date":"2025-12-19","type":"pipeline","source":"Fierce Biotech","summary":"VC Aditum Bio launches new biotech in business play with Fosun Pharma - Fierce Biotech","headline":"VC Aditum Bio launches new biotech in business play with Fosun Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5Lc3NBRFQ1MnJSVEFBaVFndGNHZWN3Y3dtNkNsVEFPTDJjNW8tTUNTV0NIY19lY25wNW1yRk9UdVlIa3J2RG5CREVQOFZNdVlaNFNGZ3VIalJzT0pUN2RJ?oc=5","date":"2025-10-02","type":"pipeline","source":"PharmaTimes","summary":"Olav Hellebø - PharmaTimes","headline":"Olav Hellebø","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxNeHh2NEpvckYza29kdGs3amRCdmlWT0tmXzFWcHd4TmNleFlTRmxuTDltUm1BRnZLSHR6d3V5cklCNHYyVER4Q2hDOGxUTVhUU2lZVGJucmV1Wm4ydmE2SUdWTkJ1RWNyZnZUYWpTNVZId0pBN2p3Z1BsLVVENFBoOUFzbw?oc=5","date":"2025-06-20","type":"trial","source":"Oncology Pipeline","summary":"Opinion: dealing with failure, iTeos style | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"Opinion: dealing with failure, iTeos style | ApexOnco - Clinical Trials news and analysis","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxQOHdES3dkbzJqZVJDRW5EYkZlb0VvdnU3VXE4M2Q0eXlES1hXN3JOTkJzODlEekFxQ3pfSThoTVBSSnNBeHdYTnhmekV3SnFWdXhTVDJOQUxZX0hILWdYdXpreEc4Tmp3T2hUS2ZpT3AxemlfLTRYb3lxcXdsY250c2c4M2lFZw?oc=5","date":"2023-08-17","type":"pipeline","source":"pharmaphorum","summary":"Changing Faces: Pharma and biotech hires from July 2023 - pharmaphorum","headline":"Changing Faces: Pharma and biotech hires from July 2023","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPblk2ck1JY29NS3lpUXhaQ1QyT3dSLURJZU1lRXJQVDBwSHBvYmtBd2FCWDRheV9fNFNwamlXWWxjZ0pmbnRuQWpNU2luZzhjckt4aUFpWjJQYUhuVXlXdWg2R0xQYWpDQzhsTTRpMzRNeTBuNU9PcUFmNmRxX3ZPZmVHYW12Y0cyUnJ0YlNFRkhmZ1A3RzRWUE5TWUVFYmhu?oc=5","date":"2019-07-01","type":"pipeline","source":"Fortune Business Insights","summary":"Chronic lymphocytic leukemia Market Size, Share, Forecast to 2034 - Fortune Business Insights","headline":"Chronic lymphocytic leukemia Market Size, Share, Forecast to 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQQi0zVE5DMEVVbGdIclc4dE9CU3F5b0dwc2hHaVJadlJMeTVCTjREeGpaa3ZlV2NqdS1qcG96bjlUUTBUOFMtRkNuUjljWlh1TU1nbXVsbkVGMHdqWDJma2h4SDlJc2k4Nm5LUFVFRTVsOWF3VW02MU1OaUZjdTRPVXFZVGlHZkhDd01ReXFSVnI0TmhJRjdXTXprMW4?oc=5","date":"2013-11-12","type":"trial","source":"Clinical Trials Arena","summary":"Volasertib for Treatment of Acute Myeloid Leukaemia (AML) - Clinical Trials Arena","headline":"Volasertib for Treatment of Acute Myeloid Leukaemia (AML)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxNNS1xV3RYMEZ4QThIWWNGc2Z1ZzB2d0hNOXg4anQ1dUJ3UGthREgzY2FEdW4zOFhmUDhaUHc1blBDbGZRVTBEQlMtTWZ6UkJwZXFNUnI2NDhpeHFQcXpRaWp0c0x4aWdjaGJyczFuX3NQdWxseUlpNjJfVEc2RVZCOFd0SXhmNUZwT2JlR0lURFl5X1BOcE5BVE5qN3Z3X0FPNzQtRjc5UVp3RUlRaHlSSGNQQ3FORS1OYWVROC1xdExoODVVSnZDbHBaUnZHeElPcjhVaEZTc2p5cGdtS2twd1Z3?oc=5","date":"2011-08-26","type":"trial","source":"Technology Networks","summary":"Clavis Pharma Expands Phase III CLAVELA Study in Patients With Acute Myeloid Leukaemia - Technology Networks","headline":"Clavis Pharma Expands Phase III CLAVELA Study in Patients With Acute Myeloid Leukaemia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE1UelpyVmpFMmtUakpvNDFkZFNMbFg4SThROUNUamM2NlpuQnlIRldvXzFfS2E1XzVsdUhQREJiZkdxcE9oUENZU05yNFlhLWxwVTRFVWxmRXdyWEJISWxKcGE3bGtCM2xwdXZSSkp5cXpicVBwb1ZN?oc=5","date":"2011-01-30","type":"trial","source":"Clinical Trials Arena","summary":"Elacytarabine (CP-4055) for Treatment of Acute Myeloid Leukaemia - Clinical Trials Arena","headline":"Elacytarabine (CP-4055) for Treatment of Acute Myeloid Leukaemia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE9HUmlmcDFmYVJJMTJxMHU2blBKRGxRYXpRMzdCQ0t5U1pIcUxhV1dRc3ZfMzdOXzNybV9RU2lXRmpXT1ktc2FiMXozV0szdnFyZTRISVlnWTg3S2x4RGVYNktJdHNLZnNkdnZNaUhjWjgwZlJxaEEzV2Q3bw?oc=5","date":"2010-01-25","type":"pipeline","source":"Pharmafile","summary":"Clavis Pharma appoints Olav Hellebø - Pharmafile","headline":"Clavis Pharma appoints Olav Hellebø","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxQTnpGUEhJTnc5Z01ZMm15VnREcVdYdUZIU0xUWlpVcmU1MnJ0RU9pa1pkbFE4UUlyVnFRY1VzbU5DYnktbi1qVWpXcEV0aU9GTzJBRlF4eTZwMy1sbGJGNk11QUZMWnhyZlNmaFE2d2IxSUNwM3VHQ2ZJSF8zZG04bjRUaDFUYWdlcW9NRmgtdW5oS2xERXlpajVqNFl0TXlUckI0UDY4MmQ1STdyd0E0SEJtb3c4MUVoejBESjZn?oc=5","date":"2009-11-25","type":"deal","source":"Technology Networks","summary":"Clavis Pharma and Clovis Oncology Sign $380 Million Partnership - Technology Networks","headline":"Clavis Pharma and Clovis Oncology Sign $380 Million Partnership","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}